NASDAQ: PHAT
Phathom Pharmaceuticals Inc Stock Ownership - Who owns Phathom Pharmaceuticals?

Insider buying vs selling

Have Phathom Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Azmi NabulsiChief Operating Officer2025-01-217,886$6.59
$51.95kSell
Terrie CurranPresident and Chief Executive2025-01-2119,109$6.59
$125.89kSell
Molly HendersonCFO and CBO2025-01-216,583$6.59
$43.37kSell
Molly HendersonCFO and CBO2024-12-191,291$8.00
$10.33kSell
Azmi NabulsiChief Operating Officer2024-12-191,118$8.00
$8.94kSell
Asit ParikhDirector2024-12-1310,000$8.13
$81.25kBuy
Frank KarbeDirector2024-12-1312,500$7.93
$99.09kBuy
Azmi NabulsiChief Operating Officer2024-07-1510,901$11.72
$127.76kSell
Terrie CurranPresident and Chief Executive2024-07-1533,848$11.72
$396.70kSell
Molly HendersonCFO and CBO2024-07-154,325$11.72
$50.69kSell

1 of 2

PHAT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHAT insiders and whales buy or sell their stock.

PHAT Shareholders

What type of owners hold Phathom Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd10.92%7,464,572$43.07MInsider
Medicxi Ventures Management Jersey Ltd10.92%7,464,572$43.07MInstitution
Jennison Associates LLC10.33%7,062,507$40.75MInstitution
James N. Topper8.58%5,863,423$33.83MInsider
Frazier Life Sciences IX LP8.54%5,842,352$33.71MInsider
Takeda Pharmaceutical Co Ltd5.49%3,755,583$21.67MInsider
Invesco Ltd5.37%3,671,386$21.18MInstitution
Blackrock Inc5.12%3,502,375$20.21MInstitution
Carlyle Group Inc5.11%3,496,808$20.18MInstitution
Ra Capital Management LP4.56%3,115,008$17.97MInsider

1 of 3

PHAT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHAT60.44%39.56%Net SellingNet Selling
CMRX25.75%32.10%Net SellingNet Selling
AURA75.29%18.46%Net SellingNet Selling
ORKA10.50%89.50%Net Buying
ATXS52.03%24.41%Net Buying

Phathom Pharmaceuticals Stock Ownership FAQ

Who owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals (NASDAQ: PHAT) is owned by 72.05% institutional shareholders, 47.16% Phathom Pharmaceuticals insiders, and 0.00% retail investors. Medicxi Ventures Management Jersey Ltd is the largest individual Phathom Pharmaceuticals shareholder, owning 7.46M shares representing 10.92% of the company. Medicxi Ventures Management Jersey Ltd's Phathom Pharmaceuticals shares are currently valued at $43.07M.

If you're new to stock investing, here's how to buy Phathom Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.